Distinct functional activity of the precuneus and posterior cingulate cortex during encoding in the preclinical stage of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 31, Issue 3, 2012, Pages 517-526

  Rami, Lorena ^a,c   Sala Llonch, Roser ^b   Solé Padullés, Cristina ^a   Fortea, Juan ^a   Olives, Jaume ^a   Lladó, Albert ^a,c   Pea Gómez, Cleofe ^b   Balasa, Mircea ^a   Bosch, Bea ^a,c   Antonell, Anna ^a,c   Sanchez Valle, Raquel ^a,c   Bartrés Faz, David ^c   Molinuevo, Jose L ^a,c  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Alzheimer's disease; biomarkers; cerebrospinal fluid; cognition; diagnosis; functional magnetic resonance imaging; preclinical phases

Indexed keywords

AMYLOID BETA PROTEIN[1-42];

AGED; ALZHEIMER DISEASE; ARTICLE; ASSOCIATION CORTEX; BOLD SIGNAL; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INDEPENDENT COMPONENT ANALYSIS; MALE; MENTAL TASK; POSTERIOR CINGULATE; PRECUNEUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SYMPTOMATOLOGY; TASK PERFORMANCE; UNIVARIATE ANALYSIS;

EID: 84865580405     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120223     Document Type: Article

References (37)

1. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65, 403-413.
2. Jack CR, Knopman DA, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.
3. Iacono D, O'Brien R, Resnick SM, Zonderman AB, Pletnikova O, Rudow G, An Y, West MJ, Crain B, Troncoso JC (2008) Neuronal hypertrophy in asymptomatic Alzheimer disease. J Neuropathol Exp Neurol 67, 578-589. (Pubitemid 351787084)
4. Mintun MA, Larossa GN, Sheline YL, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC (2006) [11C]PIB in nondemented population: Potential antecedent marker of Alzheimer disease. Neurology 67, 446-452. (Pubitemid 44214969)
5. Price J, Morris J (1999) Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 45, 358-368. (Pubitemid 29120041)
6. Fortea J, Sala-Llonch R, Bartŕes-Faz D, Bosch B, Llad́o A, Bargalĺo N, Molinuevo JL, Śanchez-Valle R (2010) Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers. J Alzheimers Dis 22, 909-922.
7. Fortea J, Sala-Llonch R, Bartŕes-Faz D, Llad́o A, Soĺe-Padulĺes C, Bosch B, Antonell A, Olives J, Sanchez-Valle R, Molinuevo JL, Rami L (2011) Cognitively preserved subjects with transitionalCSF β-amyloid 1-42 values have thicker cortex in AD vulnerable areas. Biol Psychiatry 70, 183-190.
8. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogora M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendation from the national institute of aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
9. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
10. Rami L, Fortea J, Bosch B, Soĺe-Padulĺes C, Llad́o A, Iranzo A, Śanchez-Valle R, Molinuevo JL (2011) Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients. J Alzheimers Dis 23, 319-326.
11. Prvulovic D, Bokde ALW, Faltraco F, HampelH (2011) Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease. Prog Neurobiol 95, 557-569.
12. Sheline YI, Raichle ME, Snyder AZ, Morris JC, Head D, Wang S, Mintun MA (2010) Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly. Biol Psychiatry 67, 584-587.
13. Sperling RA, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA (2009) Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 63, 178-188.
14. Hedden T, Van Dijk KR, Becker JA, Mehta A, Sperling RA, Johnson KA, Buckner RL (2009) Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci 29, 12686-12694.
15. Nelissen N, Vandenbulcke M, Fannes K, Verbruggen A, Peeters R, Dupont P, Van Laere K, Bormans G, Vandenberghe R (2007) Abeta amyloid deposition in the language system and how the brain responds. Brain 130, 2055-2069. (Pubitemid 47236621)
16. Drzezga A, Becker JA, Van Dijk KRA, Screenivasa A, Talukdar T, Sullivan C, Schultz AP, Sepulcre J, Putcha D, Greve D, Johnson KA, Sperling RA (2011) Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden. Brain 134, 1635-1646.
17. Fagan AM, Head D, Shah AR, Marcus D, Mintun M, Morris JC, Holtzman DM (2009) Decreased cerebrospinal fluid Abeta (42) correlates with brain atrophy in cognitively normal elderly. Ann Neurol 65, 176-183.
18. Antonell A, Fortea J, Rami L, Bosch B, Balasa M, Śanchez-Valle R, Iranzo A, Molinuevo Jl, Llad́o A (2011) Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints. J Neural Transm 118, 259-262.
19. Rami L, Ǵomez-Anśon B, Bosch B, Śanchez-Valle R, Monte GC, Villar A, Molinuevo JL (2007) Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 24, 274-279. (Pubitemid 47482074)
20. Soĺe-Padulĺes C, Bartŕes-Faz D, Junqúe C, Vendrell P, Rami L, Clemente IC, Bosch B, Villar A, Bargalĺo N, Jurado MA, Barrios M, Molinuevo JL (2009) Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 30, 1114-1124.
21. Beckmann CF, SmithSM (2005) Tensorial extensions of independent component analysis for multisubject FMRI analysis. Neuroimage 25, 294-311. (Pubitemid 40289157)
22. Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17, 825-841. (Pubitemid 35317016)
23. SmithSM (2002) Fast robust automated brain extraction.Hum Brain Mapp 17, 143-155. (Pubitemid 35253488)
24. Woolrich MW, Ripley BD, Brady JM, Smith SM (2001) Temporal autocorrelation in univariate linear modelling of FMRI data. NeuroImage 14, 1370-1386. (Pubitemid 33124185)
25. Buckner RL, Andrews-Hanna JR, Schacter DL (2008) The brain's default network: Anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124, 1-38. (Pubitemid 351506788)
26. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL (2001) A default mode of brain function. Proc Natl Acad Sci USA 16, 676-682. (Pubitemid 32105102)
27. Daselaar SM, Prince SE, Cabeza R (2004) When less means more: Deactivations during encoding that predict subsequent memory. Neuroimage 23, 921-927. (Pubitemid 39446526)
28. Vannini P, O'Brien J, O'Keefe K, Pihlajam̈aki M, Laviolette P, Sperling RA (2011) What goes down must come up: Role of the posteromedial cortices in encoding and retrieval. Cereb Cortex 21, 22-34.
29. Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, DePeau K, Rentz DM, Selkoe DJ, Blacker D, Albert MS, Sperling RA (2006) Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: An independent component analysis. J Neurosci 26, 10222-10231. (Pubitemid 44527415)
30. Sperling RA, Bates JF, Chua EF, Cocchiarella AJ, Rentz DM, Rosen BR, Schacter DL, Albert MS (2003) fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry 74, 44-50. (Pubitemid 36069035)
31. Miller SL, Fenstermacher E, Bates J, Blacker D, Sperling RA, Dickerson BC (2008) Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. J Neurol Neurosurg Psychiatry 79, 630-635. (Pubitemid 351829432)
32. O'Brien JL, O'Keefe KM, LaViolette PS, DeLuca AN, Blacker D, Dickerson BC, Sperling RA (2010) Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology 74, 1969-1976.
33. Winblad B, Wimo A, Engedal K, Soininen H, Verhey F, Waldemar G, Wetterholm AL, Haglund A, Zhang R, Schindler R (2006) 3-year study of donepezil therapy in Alzheimer's disease: Effects of early and continuous therapy. Dement Geriatr Cogn Disord 21, 353-363. (Pubitemid 43735680)
34. Schott JM, Bartlett JW, Fox NC, Barnes J (2010) Alzheimer's Disease Neuroimaging Initiative Investigators. Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid A-1-42. Ann Neurol 68, 825-834.
35. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR Jr, Alzheimer's Disease Neuroimaging, Initiative (2009) MRI and CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change. Neurology 73, 294-301.
36. Tosun D, Schuff N, Truran-Sacrey D, Shaw LM, Trojanowski JQ, Aisen P, Peterson R, Weiner MW, Alzheimer's Disease Neuroimaging, Initiative (2010) Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: A longitudinal MRI study. Neurobiol Aging 31, 1340-1354.
37. Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM (2007) Cerebrospinal fluid tau/beta-amyloid (42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol 64, 343-349. (Pubitemid 46425688)